Skip to main content

Utilization of Methotrexate: A Descriptive Analysis in TriNetX

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    methotrexate
    Description

    This analysis aimed to assess use of methotrexate injection formulation products in the TriNetX Live™ platform. This analysis contains data from 81 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Natural Language Processing. 

    This query was ran in two parts: the first on January 31, 2024 and February 1, 2024 and the second on February 2, 2024 and February 5, 2024. The first part contains data from January 1, 2022 to December 31, 2023. The second part contains data over two distinct query periods: August 1, 2022 to December 31, 2023, and January 1, 2022 to December 31, 2023.

    Additional Details
    FDA Center
    CDER
    Time Period
    August 1, 2022 - December 31, 2023; January 1, 2022 - December 31, 2023
    Analysis Type
    TriNetX Analysis
    Population / Cohort
    All individuals
    Data Sources
    TriNetX USA Network